VERTEX PHARMACEUTICALS INC's ticker is and the CUSIP is 92532F950. A total of 8 filers reported holding VERTEX PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,832,596 | +87.3% | 25,400 | +89.6% | 0.02% | +87.5% |
| Q2 2023 | $4,715,594 | +33.6% | 13,400 | +19.6% | 0.01% | +33.3% |
| Q1 2023 | $3,528,784 | +103.7% | 11,200 | +86.7% | 0.01% | +100.0% |
| Q4 2022 | $1,732,680 | +99.4% | 6,000 | +100.0% | 0.00% | +50.0% |
| Q3 2022 | $869,000 | +516.3% | 3,000 | +500.0% | 0.00% | – |
| Q2 2022 | $141,000 | -76.5% | 500 | -78.3% | 0.00% | – |
| Q1 2022 | $600,000 | -54.5% | 2,300 | -61.7% | 0.00% | -100.0% |
| Q4 2021 | $1,318,000 | +0.9% | 6,000 | -16.7% | 0.00% | 0.0% |
| Q3 2021 | $1,306,000 | +79.9% | 7,200 | +100.0% | 0.00% | 0.0% |
| Q2 2021 | $726,000 | -19.6% | 3,600 | -14.3% | 0.00% | 0.0% |
| Q1 2021 | $903,000 | -87.4% | 4,200 | -83.0% | 0.00% | -87.5% |
| Q2 2020 | $7,171,000 | -13.6% | 24,700 | -29.2% | 0.01% | -27.3% |
| Q1 2020 | $8,304,000 | -29.4% | 34,900 | -35.0% | 0.01% | 0.0% |
| Q4 2019 | $11,758,000 | +56.7% | 53,700 | +21.2% | 0.01% | +57.1% |
| Q3 2019 | $7,505,000 | -16.8% | 44,300 | -10.0% | 0.01% | -12.5% |
| Q2 2019 | $9,022,000 | +3.9% | 49,200 | +4.2% | 0.01% | -11.1% |
| Q1 2019 | $8,682,000 | -40.5% | 47,200 | -46.4% | 0.01% | -43.8% |
| Q4 2018 | $14,599,000 | -32.9% | 88,100 | -21.9% | 0.02% | -20.0% |
| Q3 2018 | $21,741,000 | -2.4% | 112,800 | -14.0% | 0.02% | -9.1% |
| Q2 2018 | $22,282,000 | +7.5% | 131,100 | +3.1% | 0.02% | +10.0% |
| Q1 2018 | $20,731,000 | -60.0% | 127,200 | -63.2% | 0.02% | -51.2% |
| Q4 2017 | $51,852,000 | +6.7% | 346,000 | +8.2% | 0.04% | -2.4% |
| Q3 2017 | $48,607,000 | +47.8% | 319,700 | +25.3% | 0.04% | +31.2% |
| Q2 2017 | $32,888,000 | +31.4% | 255,200 | +11.5% | 0.03% | +28.0% |
| Q1 2017 | $25,030,000 | -7.0% | 228,900 | -37.4% | 0.02% | +4.2% |
| Q4 2016 | $26,926,000 | +26.5% | 365,500 | +49.7% | 0.02% | +14.3% |
| Q3 2016 | $21,288,000 | -4.0% | 244,100 | -5.3% | 0.02% | -12.5% |
| Q2 2016 | $22,176,000 | +231.3% | 257,800 | +206.2% | 0.02% | +200.0% |
| Q1 2016 | $6,693,000 | -15.4% | 84,200 | +33.9% | 0.01% | -11.1% |
| Q4 2015 | $7,915,000 | +99.5% | 62,900 | +65.1% | 0.01% | +80.0% |
| Q3 2015 | $3,968,000 | -40.2% | 38,100 | -29.1% | 0.01% | -28.6% |
| Q2 2015 | $6,631,000 | +88.6% | 53,700 | +80.2% | 0.01% | +75.0% |
| Q1 2015 | $3,516,000 | – | 29,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 224,200 | $63,177,000 | 0.10% |
| Twin Tree Management, LP | 54,800 | $15,442,000 | 0.02% |
| JANE STREET GROUP, LLC | 161,500 | $45,509,000 | 0.02% |
| SIMPLEX TRADING, LLC | 54,100 | $15,244,000 | 0.02% |
| SG Americas Securities, LLC | 20,000 | $170,000 | 0.00% |
| JPMORGAN CHASE & CO | 6,400 | $1,803,000 | 0.00% |
| Allianz Asset Management GmbH | 500 | $141,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |